当前位置:首页 - 行情中心 - 森萱医药(920946) - 财务分析 - 现金流量表

森萱医药

(920946)

  

流通市值:40.12亿  总市值:40.13亿
流通股本:4.27亿   总股本:4.27亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金431,085,406.2297,898,059.78142,188,427.6522,434,006.33
  收到的税费返还279,060.68117,000.0126,943.37144,161.95
  收到其他与经营活动有关的现金7,033,992.12,440,644.61,213,219.1813,075,320.89
  经营活动现金流入小计438,398,458.98300,455,704.39143,428,590.15535,653,489.17
  购买商品、接受劳务支付的现金152,491,538.6280,123,133.3438,149,964.73151,798,280.77
  支付给职工以及为职工支付的现金89,853,539.3864,340,425.1837,193,726.14110,745,302.72
  支付的各项税费44,722,029.7830,255,131.549,946,215.7955,053,150.81
  支付其他与经营活动有关的现金16,328,078.412,094,657.824,998,643.2821,298,401.61
  经营活动现金流出小计303,395,186.18186,813,347.8890,288,549.94338,895,135.91
  经营活动产生的现金流量净额135,003,272.8113,642,356.5153,140,040.21196,758,353.26
二、投资活动产生的现金流量:
  收回投资收到的现金250,000,000204,000,00088,000,000303,000,000
  取得投资收益收到的现金3,336,842.292,930,611.62700,197.572,363,840.69
  处置固定资产、无形资产和其他长期资产收回的现金净额---1,800
  收到的其他与投资活动有关的现金20,000,00020,000,000--
  投资活动现金流入小计273,336,842.29226,930,611.6288,700,197.57305,365,640.69
  购建固定资产、无形资产和其他长期资产支付的现金13,185,506.779,781,833.775,196,722.69,590,535.47
  投资支付的现金360,000,000222,000,000104,000,000376,000,000
  支付其他与投资活动有关的现金184,000,00074,000,00034,000,00091,000,000
  投资活动现金流出小计557,185,506.77305,781,833.77143,196,722.6476,590,535.47
  投资活动产生的现金流量净额-283,848,664.48-78,851,222.15-54,496,525.03-171,224,894.78
三、筹资活动产生的现金流量:
  取得借款收到的现金15,000,00013,000,0003,000,000-
  收到其他与筹资活动有关的现金---200,000
  筹资活动现金流入小计15,000,00013,000,0003,000,000200,000
  偿还债务支付的现金5,200,000200,000200,000-
  分配股利、利润或偿付利息支付的现金72,421,473.2872,351,517.7312,75062,968,567.6
  其中:子公司支付给少数股东的股利、利润4,000,0004,000,000-3,200,000
  支付其他与筹资活动有关的现金1,177,799.411,177,799.41133,0181,267,653.69
  筹资活动现金流出小计78,799,272.6973,729,317.14345,76864,236,221.29
  筹资活动产生的现金流量净额-63,799,272.69-60,729,317.142,654,232-64,036,221.29
四、汇率变动对现金及现金等价物的影响-4,790,720.08-3,233,563.25-1,356,308.31-1,937,713.43
五、现金及现金等价物净增加额-217,435,384.45-29,171,746.03-58,561.13-40,440,476.24
  加:期初现金及现金等价物余额542,877,681.42542,877,681.42542,877,681.42583,318,157.66
  期末现金及现金等价物余额325,442,296.97513,705,935.39542,819,120.29542,877,681.42
补充资料:
  净利润-94,800,257.18-137,770,973.41
  资产减值准备-1,486,230.76-8,929,731.82
  固定资产和投资性房地产折旧-21,577,064.02-46,260,183.39
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-21,577,064.02-46,260,183.39
  无形资产摊销-580,180.77-1,162,341.74
  处置固定资产、无形资产和其他长期资产的损失----2,615.92
  固定资产报废损失-5,273.58-574,522.03
  公允价值变动损失--1,117,186.84--1,754,904.05
  财务费用-2,953,861.33--1,773,658.54
  投资损失--492,376.96--959,285.82
  递延所得税-448,493-1,952,934.65
  其中:递延所得税资产减少-413,048.07--604,181.12
    递延所得税负债增加-35,444.93-2,557,115.77
  存货的减少-12,718,022.41-3,139,917.31
  经营性应收项目的减少--5,291,830.65--9,497,360.2
  经营性应付项目的增加--17,288,836.03-8,195,351.81
  其他-2,544,035.45-2,182,163.11
  不涉及现金收支的投资和筹资活动金额其他项目-2,892,757.55-1,093,854.7
  现金的期末余额-513,705,935.39-542,877,681.42
  减:现金的期初余额-542,877,681.42-583,318,157.66
  现金及现金等价物的净增加额--29,171,746.03--40,440,476.24
公告日期2026-10-262026-08-262026-04-292026-04-22
审计意见(境内)标准无保留意见
TOP↑